Oestradiol enhances doxorubicin uptake and cytotoxicity in human breast cancer cells (MCF-7)

This publication has 15 references indexed in Scilit:

• Conventional versus cytokinetic polychemotherapy with estrogenic recruitment in metastatic breast cancer: results of a randomized cooperative trial.
  Journal of Clinical Oncology, 1987
• A Randomized Trial of Aminoglutethimide ± Estrogen Before Chemotherapy in Advanced Breast Cancer
  American Journal of Clinical Oncology, 1987
• Combined effects of Buserelin, estradiol and Tamoxifen on the growth of MCF-7 human breast cancer cells in vitro
  Biochemical and Biophysical Research Communications, 1986
• Influence of the Nature of Serum on the Estrogen Sensitivity of the MCF‐7 Breast Cancer Cell Line^a
  Annals of the New York Academy of Sciences, 1986
• Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer: 5-year results from the National Surgical Adjuvant Breast and Bowel Project Trial.
  Journal of Clinical Oncology, 1986
• Direct inhibitory effect of a luteinizing hormone-releasing hormone agonist on MCF-7 human breast cancer cells
  European Journal of Cancer and Clinical Oncology, 1985
• A Randomized Trial of Chemotherapy and Hormonal Therapy in Advanced Breast Cancer
  New England Journal of Medicine, 1985
• Oestrogen receptor status and the response of human breast cancer cell lines to a combination of methotrexate and 17-beta oestradiol
  British Journal of Cancer, 1985
• Cell cycle-dependent adriamycin uptake in Chinese hamster cells
  European Journal of Cancer and Clinical Oncology, 1985
• A randomized attempt to increase the efficacy of cytotoxic chemotherapy in metastatic breast cancer by hormonal synchronization.
  Journal of Clinical Oncology, 1984